SAN FRANCISCO -- Aortic valve regurgitation treated with the investigational JenaValve Trilogy appeared safe and effective in the ALIGN AR trial. The device met the safety benchmark, with a 26.7% rate ... PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

Understanding the Context

WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a ... CHICAGO — A transcatheter aortic valve implantation (TAVI) device developed specifically for the treatment for aortic regurgitation has met all the prespecified safety and efficacy goals, so far, in ... Dear Dr. Roach: During a wellness ECG in May of this year, I was diagnosed with right bundle branch block.

Key Insights

An echocardiogram indicated the following: mild mitral valve regurgitation; mild aortic valve ... MedPage Today: TAVR for Aortic Regurgitation Off to a Good Start in the Real World TAVR for Aortic Regurgitation Off to a Good Start in the Real World Dear Doctor: I am a 72-year-old man and have been diagnosed with aortic regurgitation. My cardiologist said since I’m not experiencing any of the usual symptoms connected with this, he thinks I should ... Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for patients with severe bicuspid aortic valve (BAV) stenosis. Nevertheless, these ...

Final Thoughts

Healio: ALIGN AR: ‘Intuitive’ TAVR system safe, effective for severe aortic regurgitation Please provide your email address to receive an email when new articles are posted on . A novel TAVR system was safe and effective for adults with severe aortic regurgitation who are not surgical ... TCTMD: ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ... Q: I am a 72-year-old man and have been diagnosed with aortic regurgitation. My cardiologist said since I’m not experiencing any of the usual symptoms connected with this, he thinks I should just ...